INTRODUCTION
The development of resistance of microorganisms to antimicrobial drugs in current use is on the increase. Antimicrobial resistance is one of the major challenges facing global public health. [1] The emergence of multidrugresistant isolates in tuberculosis, acute respiratory infections, and diarrhea is the major worry. This coupled with the epidemic of HIV/AIDS has increased the need for new antimicrobial agents. [2] Furthermore, the treatment of chronic infl ammatory diseases is still problematic. [3] Medical research over the past years has yielded important anti-infl ammatory drugs; steroidal and nonsteroidal. However, these drugs have numerous and severe side effects including gastric ulcers and redistribution of body fat. Therefore, agents of natural origin with relatively infrequent side effects are required. Natural products from the plant origin represent an unparalleled reservoir of molecular diversity to drug discovery and development. savanna, forest galleries, and fallow land. The leaf decoction facilitates childbirth and hastens delayed labor. The leaves are also used for dyspepsia and ulcers. The root decoction is used as an aphrodisiac, appetizer, laxative, and as a remedy for chest pains, diarrhea, dysentery, and sleeping sickness. Again, the root decoction together with guinea grains is used as a beverage and bath for paralysis. [4, 5] Apart from the investigation of the antimicrobial [6] and antioxidant effects [7] of the leaves, not much is reported on the other plant parts.
In this work, we report a comparative study of the antibacterial, anti-infl ammatory, and antioxidant properties of the leaves and bark of G. brevis.
MATERIALS AND METHODS

Collection of plant material and preparation of extracts
The plant materials used in the studies were obtained 
Animals
The animals used in this study were cockerels (Gallus gallus; strain shaver 579). They were obtained one-day post-hatch and maintained in stainless steel cages (34 × 57 × 40 cm 3 ) at 12-13 chicks per cage. They were fed on Chick Mash (GAFCO, Ghana) and allowed access to water ad libitum. An overhead incandescent illumination was maintained on a 12-h light-dark cycle chicks and room temperature was 29  1 C. Cockerels weighing between 40 and 55 g on day 7 were randomized into treatment groups and tested. Group sample sizes of 5 were used throughout the study. All procedures and techniques used in these studies were in accordance with the National Institute of Health Guidelines for the Care and Use of Laboratory Animals (NIH, Department of Health and Human Services publication No. 85-23, revised 1985) and were approved by the Ethics Committee of the Department of Pharmacology, KNUST.
Chemicals
All chemicals used were of analytical grade and purchased from Sigma Aldrich Co. Ltd., Irvine, UK. Organic solvents were also of analytical grade and purchased from BDH Laboratory Supplies (England). TLC was carried out on silica gel F 254 aluminum sheets, product code OB 315394, purchased from Merck KGaA, Germany. Diclofenac and dexamethasone were purchased from Troge, Germany and Pharm-Intas, Belgium, respectively.
Antimicrobial assays Agar well diffusion method
The agar diffusion method [8] was used to determine the antibacterial activity. Wells of 9 mm diameter were made in 20 mL nutrient agar (Oxoid) seeded with two loopfuls of a suspension of test organisms (10 5 CFU/mL) aseptically. The wells were fi lled with 100 L of the crude extracts at a concentration of 5 mg/mL in methanol. The plates were allowed to diffuse for 1 h at room temperature, incubated at 37 C for 24 h, after which zones of inhibition were measured. The test results are the mean of three replicates. Amoxycillin was included as a positive control.
Microdilution assay
Minimal inhibitory concentration (MIC) values were determined based on a micro-well dilution method. [9] Inocula of the microorganisms were prepared from the 12-h broth cultures and suspensions were adjusted to 10 5 CFU/mL.
The 96 well sterile plates were prepared by dispensing into each well 100 L of double strength nutrient broth and 100 L aliquot of the plant extract (7.8-1000 g/mL) together with 20 L of the inoculums. The microplates were incubated for 24 h at 37 C. Bacterial growth was determined after addition of a 20 L of a 5% solution of p-iodonitrotetrazolium salt (MTT) and incubating for further 30 min. Dark wells indicated the presence of microorganisms. Amoxycillin was included as a positive control. All experiments were carried out in three replicates.
Anti-infl ammatory assay Carrageenan-induced edema
The anti-infl ammatory activity was evaluated in cockerels in groups of fi ve animals for each dose, using the carrageenaninduced edema, [10] modifi ed by Woode et al. [11] Foot volumes were measured by water displacement plethysmography [12] at 0, 1, 2, 3, 4, and 5 h after subplantar injection of carrageenan (10 L of a 2% w/v solution in saline) into the right foot pad of the chicks. The test groups received the leaf extracts. Three groups of cockerels containing fi ve chicks in each group received the plant extract (30, 100, and 300 mg/kg, p.o.), bark extract (30, 100, and 300 mg/ kg, p.o.), the standard groups received diclofenac (5, 15, and 50 mg/kg, i.p.) and dexamethasone (1, 3 and 10 mg/ kg, i.p.) and the control animals received the vehicle only. All treatments were administered 30 min for i.p. route and 1 h for p.o. before carrageenan injection.
Statistical analysis
Raw scores for right foot volumes were individually normalized as percentage of change from their values at time 0 then averaged for each treatment group. The timecourse curves for foot volume was subjected to two-way (treatment × time) repeated measures analysis of variance with Bonferroni's post hoc t-test. Total foot volume for each treatment was calculated in arbitrary unit as the area under the curve (AUC). The inhibition percentage of edema was calculated for each animal group in comparison with its vehicle-treated group.
Differences in AUCs were analyzed by ANOVA followed by Newman-Keul's post hoc t-test. ED 50 (dose responsible for 50% of the maximal effect) for each drug was determined by using an iterative computer least squares method, with the following nonlinear regression (threeparameter logistic) equation:
where X is the logarithm of dose and Y is the response. Y starts at a (the bottom) and goes to b (the top) with a sigmoid shape.
GraphPad Prism for Windows version 5.00 (GraphPad Software, San Diego, CA, USA) was used for all statistical analysis and ED 50 determinations. P < 0.05 was considered statistically signifi cant.
Antioxidant assays Rapid screening for antioxidants
Methanolic solutions of extracts were spotted on silica gel sheets and developed in chloroform-methanol (9:1 v/v). The plates were sprayed with 20 mg/L of the stable free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) in methanol, antioxidant compounds in the extracts gave clear zones against a purple background. [13] Total phenol content determination
The Folin-Ciocalteu reagent was used for phenol content determination. [14] Each plant extract (1 mL of 0.125-2.5 mg/mL) in methanol was separately mixed with 1 mL Folin-Ciocalteu's reagent and 1 mL of aqueous Na 2 CO 3 (2%). The mixtures were incubated at 25C for 2 h, and then centrifuged at 10,000g for 10 min. The absorbance of the supernatant was determined at 760 nm. 1 mL methanol was processed in the same way as the test drugs and used as a blank. The standard curve was prepared by preparing tannic acid solutions (0.03-0.1 mg/mL) in methanol.
Total phenol values are expressed in terms of tannaic acid equivalents (mg/g of dry mass).
Total antioxidant capacity
Total antioxidant capacities of the extracts were determined as described by Prieto et al. [15] Different concentrations were tested for both ascorbic acid and the plant extracts: ascorbic acid (0.03-1 mg/mL); extracts (0.125-2.5 mg/ mL). One milliliter of each plant extract or ascorbic acid was separately mixed with 3 mL of reagent solution (0.6 M H 2 SO 4 , 28 mM Na 2 HPO 4 , and 4 mM ammonium molybdate), served as a positive control. The mixtures were incubated at 95 C for 90 min, and then centrifuged at 10,000g for 10 min and the absorbance of the supernatant determined at 695 nm. Methanol was processed the same way as test drugs and used as a blank. The standard curve was prepared using solutions of ascorbic acid (0.03-1 mg/ mL) in methanol. Total antioxidant values are expressed in terms of ascorbic acid equivalent (mg/g of dry mass).
Free radical scavenging activity of the ethanolic extracts
Assay was performed by the DPPH method described by Blois. [16] The absorbance of the stable free radical solution (20 mg/L in methanol) was determined as A 0 . Afterwards, 3 mL of free radical solution was added to 1 mL of the methanolic test extracts (3, 1.5, 0.75, and 0.375 mg/mL). The mixtures were allowed to stand for 30 min and absorbance was measured at 517 nm. The percentage reduction of DPPH was calculated by the following equation: DPPH scavenging activity (%) = 100(A 0 -A 1 )/A 0 .
With A 0 being the absorbance of the control and A 1 is the absorbance in the presence of the test sample. Data were presented as %DPPH scavenging effect against concentration and the IC 50 determined. All data were computed using GraphPad Prism for Windows Version 5.00 (GraphPad Software, San Diego, CA, USA).
Phytochemical screening
The preliminary phytochemical screening was performed by the standard methods. [17] 
RESULTS
Antimicrobial effects Agar well diffusion
The highest amount of inhibition was observed from the stem bark extract against B. thurigiensis ATCC 13838. The leaf extract inhibited some Gram positive organisms but none of the tested Gram negatives. However, the bark extract inhibited the growth of all the Gram positive organisms tested, Proteus vulgaris NCTC 4175, and Escherichia coli NCTC 9002 [ Table 1 ].
Micro-dilution assay
MICs were observed for the extracts that showed activity in the agar well diffusion assay. The extracts showed activity with MICs from 500 μg/mL to more than 1000 μg/mL [ Table 2 ].
Anti-infl ammatory activity
Carrageenan-induced edema
The results of the 70% ethanolic extract of the leaves and stem bark of G. brevis in carrageenan-induced foot edema were presented in Figure 1 and Table 3 . When compared with the control, the leaf and bark extracts, diclofenac and dexamethasone signifi cantly reduced the foot pad edema.
Based on the ED 50 values [ Table 3 ] obtained from the dose-response curves [ Figure 1 ], the leaf and bark extracts showed similar potencies. Both extracts were, however, found to be about four-to sixfold less potent than diclofenac and dexamethasone.
DISCUSSION
The leaves and stem bark extracts of G. brevis showed considerable antibacterial activities (MIC = 500 to >1000 μg/mL) against the tested microorganisms. Between the extracts, the stem bark was more active. It exhibited antibacterial activity against six of the eight tested bacteria strains. The leaf extract showed activity against three of the four tested Gram positive organisms with no Gram negative activity. The most prominent activities of the stem bark extract were against B. subtilis and E. faecalis with an MIC value of 500 μg/mL.
Plant secondary metabolites including: alkaloids, glycosides, triterpenoids, tannins, etc. have demonstrated antibacterial activities. [18] The presence of any one or more of these phytoconstituents [ Table 5 ] may be responsible for the observed antibacterial activities.
The cyclohexane, ethyl acetate, and methanol extracts of the leaves of G. brevis have been reported to possess antimicrobial activities. [6] In the recent study, the 70% ethanol extract of the bark of G. brevis showed wider spectrum of activity compared to the leaf extract.
Carrageenan-induced edema is biphasic and characterized by the release of serotonin and histamine in the fi rst phase. NT 500
Bacillus thurigiensis ATCC13838 >1000 1000
Staphylococcus aureus ATCC 25923
>1000
Enterococcus faecalis ATCC 29212 1000 500
Gram negative Proteus vulgaris NCTC 4175 NT 1000
Pseudomonas aeruginosa ATCC 27853
NT NT
Salmonella typhi NCTC 6017 NT NT
Escherichia coli NCTC 9002 NT >1000
All experiments were carried out in triplicates. 200 μg/mL of amoxycillin served as a positive control. MIC readings for all wells were the same. Extract: GBL, Glyphaea brevis leaves; GBB, Glyphaea brevis bark. NT = not tested. (n =5). +++P < 0.0001; ++P < 0.001; +P < 0.05 compared to vehicle-treated group (Two-way ANOVA followed by Bonferroni's post hoc test). ***P < 0.0001; **P < 0.001; *P < 0.05 compared to vehicle-treated group (One-way ANOVA followed by Newman-Keul's post hoc test. The second phase involves the release of prostaglandins. Kinins maintain the edema between the two phases. [19] This study clearly showed that the 70% ethanol extracts of the leaves and stem bark of G. brevis have anti-infl ammatory effects. Both extracts signifi cantly and equally reduced the edema produced by the subplantar injection of carrageenan. The results observed suggest an inhibitory effect, of both extracts, on the release and/or action of the mediators of infl ammation. To the best of our knowledge, this is the fi rst report of the anti-infl ammatory effects of G. brevis.
Both extracts exhibited antioxidant properties in the various assays employed. The bark extract was higher in its content of phenols [ Figure 2 ] and radical scavenging effects [ Table 4 ]. Both extracts showed similar capacities in the total antioxidant assay [ Figure 3 ].
Free radicals are often generated as by products of biological reactions or from exogenous factors and are implicated in neurodegenerative diseases, chronic ulcers, infl ammatory diseases of the airway, and many more diseases of man. [20, 21] The results noted above in the antioxidant assays validate their use in traditional medicine.
The antioxidant effects of the leaves of G. brevis using different assays have been reported before by Dakam et al. [7] However, the total antioxidant capacity, free radical scavenging, and total phenol content in the stem bark are being investigated for the fi rst time.
The extracts of the leaves and stem barks of G. brevis in this work have exhibited different extents of antibacterial, anti-infl ammatory, and antioxidant effects. These effects observed may be due to the presence of one or more of the plant secondary metabolites [ Table 5 ]. The variations in the activities of the different plant parts could be due to unequal distribution of these secondary metabolites in the different plant parts, or up to different amounts of the same metabolites.
In conclusion, the 70% ethanol extracts of the leaves and bark of G. brevis possess antibacterial, anti-infl ammatory, and antioxidant effects. In terms of antibacterial and antioxidant activities observed, the stem bark extract was the more potent. The anti-infl ammatory activities were similar. These results indicate that the traditional use of G. brevis seems quite useful and reasonable. Further isolation of the various constituents responsible for these activities is in progress in our laboratories. 
